+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Clinical evaluation of a new halcinonide-antifungal combination



Clinical evaluation of a new halcinonide-antifungal combination



Current Therapeutic Research, Clinical and Experimental 20(5): 655-660



Halcinonide-neomycin-nystatin was evaluated in a double blind trial with iodochlorhydroxyquin-hydrocortisone in the treatment of 30 patients with cutaneous Candida infections.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 000317141

Download citation: RISBibTeXText

PMID: 136333


Related references

Observations on the clinical use of a topical amphotericin B + halcinonide combination. La Clinica Terapeutica 125(3): 213-217, 1988

Evaluation of a topical steroid antibiotic combination (halcinonide-neomycin-amphotericin) in the treatment of cutaneous candidiasis and inflammatory dermatoses. Current Medical Research and Opinion 5(10): 766-771, 1979

In Vitro Antifungal Activity of Sertraline and Synergistic Effects in Combination with Antifungal Drugs against Planktonic Forms and Biofilms of Clinical Trichosporon asahii Isolates. Plos one 11(12): E0167903, 2016

A comparative clinical evaluation of a new topical steroid 'halcinonide' and hydrocortisone in steroid-responsive dermatoses. Journal of International Medical Research 4(4): 228-231, 1976

Clinical evaluation of the Sensititre YeastOne colorimetric antifungal panel for antifungal susceptibility testing of the echinocandins anidulafungin, caspofungin, and micafungin. Journal of Clinical Microbiology 46(7): 2155-2159, 2008

Clinical evaluation of the Sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazole. Journal of Clinical Microbiology 42(10): 4577-4580, 2004

Clinical evaluation of a dried commercially prepared microdilution panel for antifungal susceptibility testing of five antifungal agents against Candida spp. and Cryptococcus neoformans. Diagnostic Microbiology and Infectious Disease 50(2): 113-117, 2004

Clinical evaluation of a frozen commercially prepared microdilution panel for antifungal susceptibility testing of seven antifungal agents, including the new triazoles posaconazole, ravuconazole, and voriconazole. Journal of Clinical Microbiology 40(5): 1694-1697, 2002

Evaluation of antifungal combination against Cryptococcus spp. Mycoses 59(9): 585-593, 2016

Topical treatment of inflammatory dermatoses and cutaneous candidiasis with a new cortico-steroid-antibiotic combination: halcinonide-neomycin-amphotericin. British Journal of Clinical Practice 31(4): 33-35, 1977

A double-blind comparison of a new combination (halcinonide-neomycin-amphotericin) and active controls in cutaneous candidiasis and steroid-responsive dermatoses. Journal of International Medical Research 4(4): 232-236, 1976

Statistic evaluation of a multicentric test with halcinonide. Actas Dermo-Sifiliograficas 70(1-2): 157-174, 1979

Antifungal combination therapy: clinical potential. Drugs 65(11): 1461-1480, 2005

Evaluation of a Topical Anti-inflammatory/Antifungal Combination Cream in Mild-to-moderate Facial Seborrheic Dermatitis: An Intra-subject Controlled Trial Examining Treated vs. Untreated Skin Utilizing Clinical Features and Erythema-directed Digital Photography. Journal of Clinical and Aesthetic Dermatology 8(9): 33-38, 2015

Evaluation of a new halcinonide formulation in the treatment of common dermatoses. Cutis 30(2): 262-266, 1982